Cetera Advisor Networks LLC Catalyst Pharmaceuticals, Inc. Transaction History

Cetera Advisor Networks LLC

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$11.78 - $17.29 $5,088 - $7,469
432 Added 4.14%
10,857 $182,000
Q3 2023

Nov 14, 2023
BUY
$11.69 - $15.02 $121,868 - $156,583
10,425 New
10,425 $121,000
Q1 2022

May 12, 2022
BUY
$5.31 - $8.31 $6,701 - $10,487
1,262 Added 6.3%
21,308 $177,000
Q4 2021

Feb 14, 2022
BUY
$5.21 - $7.45 $104,439 - $149,342
20,046 New
20,046 $136,000

Others Institutions Holding CPRX

# of Institutions
327
Shares Held
94.1M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.33B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email